Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
(PA-20-135)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Human Genome Research Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
National Library of Medicine
Office of Research on Women's Health
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s):
See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Development and Maintenance of the Animal Feed Regulatory Program Standards with Optional Coordinated Preventive Control Regulatory Activities and Capacity Building (U18) Clinical Trial Not Allowed
(PAR-20-132)
Food and Drug Administration
Application Receipt Date(s):
May 13, 2020 by 11:59 PM Eastern Time.
February 15, 2021 by 11:59 PM Eastern Time.
February 15, 2022, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
(PAR-20-137) Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
Office of Research on Women's Health
Application Receipt Date(s):
June 5, 2020 (new) and July 5, 2020 (renewal, resubmission, revision); October 5, 2020 (new) and November 5, 2020 (renewal, resubmission, revision); June 5, 2021 (new) and July 5, 2021 (renewal, resubmission, revision); October 5, 2021 (new) and November 5, 2021 (renewal, resubmission, revision); June 5, 2022 (new) and July 5, 2022 (renewal, resubmission, revision); October 5, 2022 (new) and November 5, 2022 (renewal, resubmission, revision)
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
(PAR-20-139)
National Institute of Allergy and Infectious Diseases
National Institute on Aging
Application Receipt Date(s):
May 13, 2020; September 13, 2020; January 13, 2021; May 13, 2021; September 13, 2021; January 13, 2022; May 13, 2022; September 13, 2022; January 13, 2023
Artificial Intelligence and Technology Collaboratories for Aging Research (P30 Clinical Trial Optional)
(RFA-AG-21-009)
National Institute on Aging
Application Receipt Date(s):
October 1, 2020. No late applications will be accepted for this funding opportunity announcement.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed)
(RFA-AG-21-019)
National Institute on Aging
Application Receipt Date(s):
September 15, 2020
All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply corrections to errors found in the application during the submission process by the due date.
NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed)
(RFA-AR-21-004)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s):
August 11, 2020, by 5:00 PM local time of applicant organization.
All applications are due by 5:00 PM local time of applicant organization. All allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed)
(RFA-DK-20-006)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s):
July 22, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Retail Food Safety Association Collaboration (U18) Clinical Trial Not Allowed
(RFA-FD-20-028)
Food and Drug Administration
Application Receipt Date(s):
May 13, 2020, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional
(RFA-FD-20-030)
Food and Drug Administration
Application Receipt Date(s):
May 11, 2020, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
Incorporating cost effectiveness & societal outcomes into FDA opioids model (U01) Clinical Trials Not Allowed
(RFA-FD-20-031)
Food and Drug Administration
Application Receipt Date(s):
May 18, 2020, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
Population Dynamics Centers Research Infrastructure Program FY 2021 (P2C Clinical Trial Not Allowed)
(RFA-HD-21-010) Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s):
July 30, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Postdoctoral Training in Pediatric Clinical Pharmacology (T32 Clinical Trial Not Allowed)
(RFA-HD-21-014) Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s):
May 27, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-HG-20-019)
National Human Genome Research Institute
Application Receipt Date(s):
June 24, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.